OpenVSafe by OpenVAERS
Search V-safe

ZAK-29581-03810

2 vaccinations 9 coded responses 21 check-ins 9 free-text entries 15 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
880 / NM
Registered
2020-12-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-18
    Registered in v-safe
  2. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-18
    Health check-in — day 0, dose 1
    Feeling: Fair · Headache, Nausea
    Adult check-in
  4. 2020-12-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  5. 2020-12-19
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  6. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  7. 2020-12-20
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  8. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Nausea
    Adult check-in
  9. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Nausea
    Adult check-in
  10. 2020-12-27
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-01
    Survey response — day 14, dose 1
    MedDRA: Abdominal pain upper, Headache, Nausea — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Headaches, nausea/stomach pain has returned
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-01
    Report sent to call center — day 14, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  13. 2021-01-07
    Dose 2 — Pfizer-BioNTech
  14. 2021-01-08
    Survey response — days 1–6 daily, dose 2
    MedDRA: Asthenia, Headache, Syncope — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Free text: Headache, syncope, weakness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-08
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  16. 2021-01-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  17. 2021-01-10
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  18. 2021-01-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  19. 2021-01-11
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  20. 2021-01-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  21. 2021-01-12
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  22. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  23. 2021-01-13
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  24. 2021-01-14
    Health check-in — day 7, dose 2
    Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Adult check-in
  25. 2021-01-14
    Report sent to call center — day 7, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  26. 2021-01-21
    Survey response — day 14, dose 2
    MedDRA: Rash — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: I have developed a rash/almost abscess on my forehead. Very painful, feels like how people describe shingles. Been using hot packs, steroids and on a 10 day antibiotic regimen.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-01-21
    Report sent to call center — day 14, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  28. 2021-01-28
    Survey response — day 21, dose 2
    MedDRA: Herpes zoster — Feeling: Poor · Be unable to work
    Free text: Been diagnosed with shingles and it is in my eye.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  29. 2021-02-04
    Survey response — day 28, dose 2
    MedDRA: Herpes zoster — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Shingles in my eye
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  30. 2021-02-04
    Report sent to call center — day 28, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  31. 2021-02-11
    Survey response — day 35, dose 2
    MedDRA: Herpes zoster, Medical observation — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Shingles have returned and on a second round of anti-virals. Acyclovir 800mg, 5 times a day for 10 days. It has spread to the torso and the opposite side of the first outbreak. · Healthcare visit (other): Optometrist
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  32. 2021-02-11
    Report sent to call center — day 35, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  33. 2021-02-18
    Survey response — day 42, dose 2
    MedDRA: Herpes zoster, Office visit — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Shingles returned · Healthcare visit (other): Optometrist
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  34. 2021-02-18
    Report sent to call center — day 42, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  35. 2021-04-08
    Survey response — 3 months, dose 2
    MedDRA: Condition aggravated, Herpes zoster, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Return of shingles
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  36. 2021-04-08
    Report sent to call center — 3 months, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  37. 2021-05-10
  38. 2021-05-12
    Call successful
    Does not wish to fill out VAERS report
  39. 2021-07-08
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  40. 2022-01-07
    Survey response — 12 months, dose 2
    MedDRA: Cough, Pyrexia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: High fever, cough. Negative PCR.
    MedDRA releases: 2024-11 · check-in free text available
  41. 2022-01-07
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  42. 2022-01-10
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-07Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2020-12-19 priority 2/3
2020-12-20 priority 2/3
2021-01-01 priority 2/3
2021-01-08 priority 2/3
2021-01-10 priority 2/3
2021-01-11 priority 2/3
2021-01-12 priority 2/3
2021-01-13 priority 2/3
2021-01-14 priority 2/3
2021-01-21 Successful Does not wish to fill out VAERS report
2021-02-04 Successful Does not wish to fill out VAERS report
2021-02-11 Successful Does not wish to fill out VAERS report
2021-02-18 Successful Does not wish to fill out VAERS report
2021-04-08 Successful
2021-05-12
Does not wish to fill out VAERS report
2022-01-07 Successful
2022-01-10
Participant prefers to complete VAERS report online

Free text

Release 1 — day 14, dose 1

2021-01-01

Symptoms: Headaches, nausea/stomach pain has returned

Release 1 — days 1–6 daily, dose 2

2021-01-08

Systemic reaction (other): Headache, syncope, weakness

Release 2 — day 14, dose 2

2021-01-21

Symptoms: I have developed a rash/almost abscess on my forehead. Very painful, feels like how people describe shingles. Been using hot packs, steroids and on a 10 day antibiotic regimen.

Release 2 — day 21, dose 2

2021-01-28

Symptoms: Been diagnosed with shingles and it is in my eye.

Release 3 — day 28, dose 2

2021-02-04

Symptoms: Shingles in my eye

Release 4 — day 35, dose 2

2021-02-11

Symptoms: Shingles have returned and on a second round of anti-virals. Acyclovir 800mg, 5 times a day for 10 days. It has spread to the torso and the opposite side of the first outbreak.
Healthcare visit (other): Optometrist

Release 4 — day 42, dose 2

2021-02-18

Symptoms: Shingles returned
Healthcare visit (other): Optometrist

Release 7 — 3 months, dose 2

2021-04-08

Symptoms: Return of shingles

Release 10 — 12 months, dose 2

2022-01-07

Symptoms: High fever, cough. Negative PCR.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical observation ✓ ✓ ✓
HCVOOffice visit ✓ ✓ ✓
SDAbdominal pain upper ✓ ✓ ✓
SDCondition aggravated ✓ ✓ ✓
SDCough · · ✓
SDHeadache ✓ ✓ ✓
SDHerpes zoster ✓ ✓ ✓
SDNausea ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDPyrexia · · ✓
SDRash ✓ ✓ ✓
SROAsthenia ✓ ✓ ✓
SROHeadache ✓ ✓ ✓
SROSyncope ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release